SynthesisScientific reports2023

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.

Takhyeon Kweon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.